SOD1 and amyotrophic lateral sclerosis: Duan et al. reported that CRISPR/Cas9 targeting SOD1G93A mutations was delivered by AAV9 vehicles to ALS transgenic mice, disrupting the mutant SOD1 gene and increasing the lifetime of the mice by up to 54.6%.